Eric Broyles

Eric Broyles is a Washington, DC based entrepreneur who began his career as an attorney.  Eric is the Founder & CEO of Nanocan Therapeutics Corporation.  Nanocan has the worldwide exclusive rights from Harvard’s Dana Farber Cancer Institute to a patented nanoparticle-based oncology therapeutic that has demonstrated breakthrough results in both pre-clinical and animal studies for treating certain cancers, including pancreatic, prostate, breast, cervical, lung cancers and potentially glioblastoma.  Eric also is the Founder & Chairman of ExpertConnect Litigation Support one of the leading expert witness search and placement firms in the US.  ExpertConnect has a network of over 150,000 subject matter experts who provide consulting and expert witness services to over 80% of the AmLaw top 100 US law firms and several Fortune 500 companies.

Eric began his career as corporate attorney at the Washington, DC office of Skadden, Arps, Slate, Meagher & Flom.  He then became corporate counsel for AOL and AOL Time Warner where he served as Senior Counsel.  He served as a judicial law clerk on the United States Court of Appeals for the Eleventh Circuit for the Honorable Chief Judge Joseph W. Hatchett.  Eric is a 1995 graduate of the University of Virginia School of Law where he served as Business Editor of the Virginia Journal of Law & Politics and is a summa cum laude graduate of the University of Cincinnati where he double majored in Marketing and Management and was Valedictorian of his graduating class.  The Eric C. Broyles Student Success Scholarship at the University of Cincinnati has provided over 60 scholarships to first generation college students from an endowment Eric established in 2019.

Eric currently serves as the President of the Alumni Council for the University of Virginia School of Law and also serves on the Board of Trustees for the University of Cincinnati Foundation.  Eric also serves on the Board of Trustees of Hill City Church DC.